Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke
- PMID: 17344571
- PMCID: PMC2599987
- DOI: 10.1136/pgmj.2006.051094
Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke
Abstract
Up to 40% of acute ischaemic strokes in young adults are cryptogenic in nature, that is, no cause is determined. In more than half of these patients, patent foramen ovale (PFO) is seen along with an increased incidence of atrial septal aneurysm. The commonest method of investigation is echocardiography (preferably transoesophageal echocardiography). On the basis of available evidence, low risk patients are treated with antiplatelet agents and high risk patients with warfarin. There are inconclusive data on the efficacy of PFO closure to prevent stroke recurrence. However, if there is recurrent stroke or intolerance to medical therapy, percutaneous closure is carried out.
Conflict of interest statement
Competing interests: None declared.
References
-
- Sacco R L, Ellenberg J H, Mohr J P.et al Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 198925382–390. - PubMed
-
- Leys D, Bandu L, Henon H.et al Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology 20025926–33. - PubMed
-
- Hagen P T, Scholz D G, Edwards W D. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 19845917–20. - PubMed
-
- Lechat P, Mas J L, Lascault G.et al Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 19883181148–1152. - PubMed
-
- Laperche T, Laurian C, Roudaut R.et al Mobile thromboses of the aortic arch without aortic debris: a transesophageal echocardiographic finding associated with unexplained arterial embolism. Circulation 199796288–294. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
